Failed coronary thrombolysis

Lancet

Volumn 351, Issue 9110, 1998, Pages 1191-1196

  Davies, C H ^a   Ormerod, O J M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ANGIOPLASTY; BLOOD CLOT LYSIS; CORONARY ARTERY THROMBOSIS; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION; REVIEW; ST SEGMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE;

EID: 0032542941     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)11198-9     Document Type: Review

References (64)

1. 1 Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications of fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
2. 2 The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
3. 3 Neuhaus KL, von Essen R, Tebbe U, et al. Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study: a study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte (ALKK). Circulation 1994; 90: 1638-42.
4. 4 Simes RJ, Topol EJ, Holmes DR Jr, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion, and GUSTO-I Investigators. Circulation 1995; 91: 1923-28.
5. 5 Anderson JL, Karagounis LA, Califf RM: Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol 1996; 78: 1-8.
6. 6 Schroder R, Dissmann R, Bruggemann T, et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 1994; 24; 384-91.
7. 7 Mauri F, Maggioni AP, Franzosi MG, et al. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent: a Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-derived analysis. J Am Coll Cardiol 1994: 24; 600-07 (erratum 1995; 25: 805).
8. 8 Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens: a substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 1995; 26; 1657-67.
9. 9 Purcell IF, Newall N, Farrer M. Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes. Heart 1997; 78: 465-71.
10. 10 Prendergast BD, Shandall A, Buchalter MB. What do we do when thrombolysis fails?: a United Kingdom survey. Int J Cardiol 1997; 61: 39-42.
11. 11 van't Hof AWJ, Liem A, de Boer M. Zwolle myocardial infarction study group: clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 1997; 350; 615-19.
12. 12 Kern MJ, Moore JA, Aguirre FV, et al. Determination of angiographic (TIMI grade) blood flow by intracoronary doppler flow velocity during acute myocardial infarction. Circulation 1996; 94: 1545-52.
13. 13 Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996; 93; 1993-99.
14. 14 Brugemann J, van der Meer J, Takens BH, Hillege H, Lie KI. A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction. Br Heart J 1990; 64: 355-58.
15. 15 Ostermann H, Schmitz Huebner U, Winderler J, Bar F, Meyer J, van de Loo J. Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction - results from the PRIMI trial. Eur Heart J 1992; 13: 1225-32.
16. 16 Ho CH, Wang SP. Serial thrombolysis-related changes after thrombolytic therapy with TPA in patients with acute myocardial infarction. Thromb Res 1990; 58; 331-41.
17. 17 el Gaylani N, Davies S, Tovey J, Kinnarid T, Duly E, Buchalter MB. Systemic lytic state is not a predictor of coronary reperfusion in acute myocardial infarction. Int J Cardiol 1996; 57: 45-50.
18. 18 Gulba DC, Barthels M, Westhoff Bleck M, et al. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction: relevance for the success of therapy. Circulation 1991; 83: 937-44.
19. 19 Scharfstein JS, Abendschein DR, Eisenberg PR, et al, and TIMI-5 Investigators. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction: thrombolysis in myocardial infarction. Am J Cardiol 1996; 78: 503-10.
20. 20 Fears R, Hearn J, Standring R, Anderson JL, Marden VJ. Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction. Am Heart J 1992; 124: 305-14.
21. 21 Moliterno DJ, Lange RA, Meidell RS, et al. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction. Circulation 1993; 88: 935-40.
22. 22 Mattfeldt T, Schwarz F, Schuler G Hofmann M, Kubler W. Necropsy evaluation in seven patients with evolving acute myocardial infarction treated with thrombolytic therapy. Am J Cardiol 1984; 54: 530-34.
23. 23 Richardson SG, Allen DC, Morton P, Murtagh JG, Scott ME, O'Keeffe DB. Pathological changes after intravenous streptokinase treatment in eight patients with acute myocardial infarction. Br Heart J 1989; 61: 390-95.
24. 24 Onodera T, Fujiwara H, Tanaka M, et al. Cineangiographic and pathological features of the infarct related vessel in successful and unsuccessful thrombolysis. Br Heart J 1989; 61: 385-89.
25. 25 Parise P, Agnelli G. Thrombus resistance to lysis and reocclusion after thrombolysis: the role of platelets. Blood Coagul Fibrinolysis 1991; 2: 749-58.
26. 26 Iliceto S, Marangelli V, Marchese A, Amico A, Galiuto L, Rizzon P. Myocardial contrast echocardiography in acute myocardial infarction: pathophysiological background and clinical aplications. Eur Heart J 1996; 17: 344-53.
27. 27 Nicolau JC, Lorga AM, Garzon SA, et al. Clinical and laboratory signs of reperfusion: are they reliable? Int J Cardiol 1989; 25: 313-20.
28. 28 Califf RM, O'Neil W, Stack RS, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988; 108: 658-62.
29. 29 Kircher BJ, Topol EJ, O'Neil WW, Pitt B. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. Am J Cardiol 1987; 59: 513-15.
30. 30 Christenson RH, Ohman EM, Topol EJ, et al. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatinine-kinase-MB and clinical variables. Circulation 1997; 96: 1776-82.
31. 31 Clemmensen P, Ohman EM, Sevilla DC, et al. Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. Am J Cardiol 1990; 66: 1407-11.
32. 32 Saran RK, Been M, Furniss SS, Hawkins T, Reid DS. Reduction in ST Segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function. Br Heart J 1990; 64: 113-17.
33. 33 Shah PK, Cercek B, Lew AS, Ganz W. Angiographic validation of bedside markers of reperfusion. J Am Coll Cardiol 1993; 21: 55-61.
34. 34 Klootwijk P, Langer A, Meij S, et al. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J 1996; 17: 689-98.
35. 35 Willems JL, Willems RJ, Willems GM, Arnold AE, Van de Werf F, Verstraete M. Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction: European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator. Circulation 1990; 82: 1147-58.
36. 36 Mauri F, Gasparini M, Barbonaglia L, et al. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). Am J Cardiol 1989; 63: 1291-95.
37. 37 Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987; 317: 1055-59.
38. 38 Veldkamp RF, Green CL, Wilkins ML, et al, and Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study Group. Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Am J Cardiol 1994; 73: 1069-74.
39. 39 Krucoff MW, Green CL, Trollinger KM, et al. Temporal distribution of important ECG information in patients with MI: when should you take the next ECG after lytics? J Am Coll Cardiol 1997; 29: 131 (abstr).
40. 40 Kusniec J, Solodky B, Klainmann, E, Zlotikamien B, Sclarovsky S. The relationship between the electrocardiographic pattern with TIMI flow class and ejection fraction in patients with a first acute anterior wall myocardial infarction. Eur Heart J 1997; 18: 420-25.
41. 41 Laperche T, Steg PG, Benessiano J, et al. Patterns of myoglobin and MM creatine kinase isoforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implications for the early noninvasive diagnosis of reperfusion. Am J Cardiol 1992; 70: 1129-34.
42. 42 Abe S , Aeima S, Yamashita T, et al. Early assessment of reperfusion therapy using cardiac troponin T. J Am Coll Carduiol 1994; 23: 1382-89.
43. 43 Apple FS, Henry TD, Berger CR, Landt YA. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol 1996; 105: 6-10.
44. 44 Ishii J, Nagamura Y, Nomura M, et al. Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid-binding protein. Clin Chim Acta 1997; 262: 13-27.
45. 45 Lavin F, Kane M, Forde A, Gannon F, Daly K. Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. Br Heart J 1995; 73: 422-27.
46. 46 Ishii J, Nomura M, Ando T, et al. Early detection of successful coronary reperfusion based on serum myoglobin concentration: comparison with serum creatine kinase isoenzyme MB activity. Am Heart J 1994; 128: 641-48.
47. 47 Laperche T, Steg PG, Dehous M, et al, and the PERM Study Group (Prospective Evaluation of Reperfusion Markers). Circulation 1995; 92: 2079-86.
48. 48 Stauffer J, Urban P, Bleed D, et al. Results of the Swiss multicenter evaluation of early angioplasty for shock following myocardial infarction. Circulation 1997; 96 (suppl I): 1-206 (abstr).
49. 49 Berger PB, Holmes DR Jr, Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial: an observational study. Circulation 1997; 96: 122-27.
50. 50 Hochman JS, Boland J, Sleeper LA, et al, and SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 1995; 91: 873-81.
51. 51 Belenkie I, Traboulsi M, Hall CA, et al. Rescue angioplasty during myocazrdial infarction has a beneficial effect on mortality: a tenable hypothesis. Can J Cardiol 1992; 8: 357-62.
52. 52 Califf RM, Topol EJ, Stack RS, et al. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: results of thrombolysis abnd angioplasty in myocardial infarction - phase 5 randomized trial. TAMI Study Group. Circulation 1991; 83: 1543-56.
53. 53 Ellis SG, da Silva ER, Heyndrickx G, et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994; 90: 2280-84.
54. 54 Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995; 91: 476-85.
55. 55 Steinhubl SR, Topol EJ. Stenting for acute myocardial infarction. Lancet 1997; ??: 532-33.
56. 56 Lefkovits J, Ivanhoe RJ, Califf RM, et al. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction EPIC investigators. Am J Cardiol 1996; 77; 1045-51.
57. 57 The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336; 1621-28.
58. 58 Ishihara M, Sato H, Tateishi H, et al. Intraaortic balloon pumping as adjunctive therapy to rescue coronary angioplasty after failed thrombolysis in anterior wall acute myocardial uinfarction. Am J Cardiol 1995; 76: 73-75.
59. 59 Ohman EM, George BS, White CJ, et al, and the Randomized IABP Study Group. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction: results of a randomized trial. Circulation 1994; 90: 792-99.
60. 60 Kono T, Morita H, Nishina T, et al. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol 1996; 28: 876-81.
61. 61 Mounsey JP, Skinner JS, Hawkins T. Rescue thrombolysis: altephase as adjuvant treatment after streptokinase in acute myocardial infarction. Br heart J 1995; 74: 348-53.
62. 62 LeBreton H, Topol E, Plow EF. Evidence for a pivotal role of platelets in vascular reocclusion and restenosis. Cardiovasc Res 1996; 31: 235-36.
63. 63 Kleiman NS, Ohman EN, Califf RM, et al. Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 pilot study. J Am Coll Cardiol 1993; 22; 381-89.
64. 64 Ohman EM, Kleiman NS, Gacioch G, et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction: results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation 1997; 95: 846-54.